readthroughSign in
CompanyDMACNasdaqMinneapolis, MN

DiaMedica Therapeutics Inc

DiaMedica Therapeutics develops DM199, a recombinant KLK1 protein for acute ischemic stroke, preeclampsia, and fetal growth restriction.

10-QNov 12Latest SEC filing
Nov 12Latest story